SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

this coin is scarce

SCARCE CRYPTO is trending as social media buzz points to a potential breakout, with community members noting its "coiled" chart pattern and "understated strength." The coin, associated with the Solana ecosystem, is being watched for a major move as participants speculate about whale accumulation and a possible surge.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

StarkNet ($STRK) is trending as community members highlight its potential for a significant breakout, fueled by renewed accumulation and a reclaim of key support levels. Discussions revolve around StarkNet's integration with Zcash ($ZEC) to bring privacy and scalability to Layer 2, with many seeing it as a bullish development. Increased developer activity and protocol upgrades further contribute to the positive sentiment.

To honor the incredible bravery of Daboo, a heartfelt movement has been created to keep his memory alive The initiative celebrates Daboo's unwavering loyalty and courage while promoting causes that align with his heroic spirit, such aS animal rescue efforts, shelter funding, and pet safety awareness Through storytelling, Daboo's legacy serves as a reminder of the selfless love that animals offer to humans. By sharing his story and supporting these meaningful causes, the memory of Daboo continues to inspire kindness and compassion, ensuring his heroic act is never forgotten No Rug Pulls, No Get Rich Scams. Just Pure love for the meme coins!

Daboo

DABOO is trending as the community discusses its potential and recent price action, with some users highlighting its small supply and AI aspects. There's also discussion around potential connections to other cryptocurrencies like BTC, SOL and ETH, as well as comparison to other tokens. However, some users are also expressing concerns about bots and potential scam activity.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as its community rallies around a shared vision, emphasizing their strong belief in the project's long-term success, particularly within the Solana ecosystem. Active community members are encouraging each other to stay focused and united, aiming to outperform other projects. The community's enthusiasm is palpable, with members expressing readiness for upcoming developments.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community buzzes around potential catalysts and upcoming integrations like ZAP. Some users highlight the coin's strong community and potential for growth within the Bitcoin ecosystem, with many expressing a bullish outlook.

Aris Mining Corp. engages in the provision of gold mining services. It operates through the Segovia, Soto Norte, Toroparu, Juby and Marmato mines in Colombia. The company was founded in 1982 and is headquartered in Vancouver, Canada.

Aris Mining Corp

Aris Mining Corporation

Aris Mining ($ARMN) is gaining attention as a junior gold miner with significant upside, particularly due to its projects in South America. Community discussions revolve around its attractive valuation, organic growth potential, and comparisons to larger mining companies. Recent news includes positive developments from the Soto Norte project and increased ownership, contributing to the stock's trending status.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending as community members discuss its potential to follow ZEC's recent surge, emphasizing DASH's limited supply and increased interest in privacy coins. The community is anticipating a breakout past key resistance levels, with some speculating on factors that could contribute to a significant rally. Bullish sentiment is building around DASH's potential for growth.

zkSync

ZK Crypto (zkSync) is trending as the community discusses its potential for growth and recent news around partnerships and technological advancements. Some are pointing to upcoming token unlocks as a potential headwind, while others highlight integrations and real-world asset tokenization efforts as bullish catalysts. Community members are actively debating entry points and long-term price targets, with some expressing excitement about its role in Ethereum scaling.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the crypto market experiences volatility, sparking debates about potential bottom prices and future growth. Community sentiment is mixed, with some seeing buying opportunities amidst the dips, while others express concerns about market manipulation and the prevalence of meme coins on the Solana blockchain. The overall discussion revolves around whether Solana can maintain its position against other cryptos like Ethereum and Bitcoin.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Airbnb is trending as the community discusses potential integration with Instacart and debates the company's valuation amidst fluctuating market conditions. Some analysts are adjusting price targets, while others express concerns about growth and competition, particularly with hotels; discussion around new offerings such as hotels on the platform have been debated.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenon Pharmaceuticals Inc. $XENE Shares Sold by Candriam S.C.A.

Candriam S.C.A. lowered its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 12.8% during the second quarter, according to its most recent disclosure with the Securities and...

Nan Fung Trinity HK Ltd. Takes $4.96 Million Position in Xenon Pharmaceuticals Inc. $XENE

Nan Fung Trinity HK Ltd. bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the second quarter, according to the company in its most recent disclosure with the...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen research firms that are covering the firm, MarketBeat reports. One analyst...

FY2029 EPS Estimate for Xenon Pharmaceuticals Cut by Analyst

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) - Equities researchers at Wedbush cut their FY2029 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a report issued on Tuesday...

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

XENE reports narrower-than-expected Q3 loss as the biotech advances multiple late-stage studies of azetukalner across epilepsy and mood disorders.

Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?

Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus

XENE's wider Q2 loss highlights its push toward late-stage epilepsy, depression, and bipolar disorder studies with azetukalner.

Biogen shares slipped on Monday after the company said it expects to take a $46 million charge in the second quarter related to R&amp;D deals and milestone payments.&nbsp;The expense is set to shave&nbsp;off about $0.26 off its per-share earnings, both on a GAAP and adjusted basis.The update adds to investor caution following the FDA’s recent signal report published on June 30, which named Biogen’s Alzheimer’s treatment Leqembi as one of several drugs flagged for potential post-marketing safety concerns.&nbsp;The report, compiled from the FDA’s FAERS database, represents a push for increased transparency around adverse event reporting.Analysts at RBC Capital said they do not anticipate major regulatory fallout, noting that the data was already publicly available and the risks broadly acknowledged.&nbsp;However, they said the FDA’s move could still create some sentiment overhang for Biogen and other named firms, including Sarepta, Alkermes, Biohaven, Xenon, and Argenx.<a href="https://stocktwits.com/symbol/BIIB">Biogen’s</a> newly itemized R&amp;D charges follow its Q1 decision to present such costs as a separate line item on its income statement.&nbsp;The company stated that these typically include expenses from licensing deals and asset acquisitions, which are accounted for as in-process research and development.Meanwhile, Biogen is advancing its drug pipeline, beginning a Phase 3 study with felzartamab, which can treat a kidney condition known as primary membranous nephropathy.The trial, dubbed Prominent, began dosing patients late last month and will enroll about 180 adults.On Stocktwits, retail sentiment for Biogen was ‘bullish’ amid ‘low’ message volume.Biogen’s stock has declined 13.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the logo of Biogen is seen on a smartphone with the FDA logo in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)  

Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit

The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.

Equity

Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?

Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Xenon Pharmaceuticals Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.19	--	--	N/A
Q3 '25	-$1.15	-$1.15	0.21%	BEAT
Q2 '25	-$0.99	-$1.07	-8.36%	MISSED
Q1 '25	-$0.91	-$0.83	8.30%	BEAT
Q4 '24	-$0.86	-$0.84	2.39%	BEAT

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest XENE News

XENEXenon Pharmaceuticals Inc